Bacillus velezensis DSM 33864

· Novozymes A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bacillus velezensis DSM 33864, covering 2024-11-22 to 2024-11-22. Get the full timeline:

Most recent: Clinical Trial Update: Bacillus Velezensis DSM 33864 for Reduction of the Risk of Recurrent Clostridioides Difficile Infections [NA]